US 8501727
Short acting benzothiazepine calcium channel blockers and uses thereof
granted A61KA61K31/554A61P
Quick answer
US patent 8501727 (Short acting benzothiazepine calcium channel blockers and uses thereof) held by Milestone Pharmaceuticals Inc. expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Milestone Pharmaceuticals Inc.
- Grant date
- Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/554, A61P, A61P7/00, A61P9/10